Nouvelles
Découvrez les dernières nouvelles et les développements en IA et en apprentissage automatique dans le domaine de la thérapie guidée par imagerie (TGI) au Canada.
INOVAIT awards two leading companies and one academic partner for transforming Canada’s healthcare ecosystem
TORONTO, April 25, 2024 /CNW/ - INOVAIT, the national network for commercializing breakthroughs in image-guided therapy (IGT) and artificial intelligence, presented the inaugural INOVAIT awards at its annual Discovery Forum last week (April 18, 2024). The awards were established to recognize INOVAIT members (Industry and Academic) who are developing breakthrough innovations in healthcare and spearheading economic development for Canada. "The INOVAIT awards grew out of our desire to recognize and spotlight members and institutions doing exceptional things to impact medtech innovation in Canada," said Raphael Ronen, co-executive director of INOVAIT. "Together, the recipients of the 2024 INOVAIT awards showcase Canada's…
PulseMedica is laser-focused on tackling vitreoretinal diseases
The PulseMedica platform is a 3D image-guided therapy device that integrates powerful laser therapy, advanced medical imaging, and limitless machine learning (ML) for precision imaging and treatment of vitreoretinal disease. Vitreoretinal diseases exist within the clear gel (vitreous fluid) that fills the eye and retina at the back of the eye. PulseMedica’s device strives to automate the imaging and treatment process, enabling quick and precise disease targeting, thereby reducing the treatment time and reducing the risk of side effects and total time per patient, allowing for more patients to be treated each day.
Sonic Incytes is making liver screening more accessible
Sonic Incytes, a Canadian artificial intelligence (AI)-assisted medical imaging company based out of Vancouver, British Columbia, is looking to change the way liver disease is screened and monitored globally. Their flagship, FDA cleared device, Velacur™, is revolutionizing the diagnosis and management of chronic liver disease. Their proprietary technology that grew into Velacur was originally developed by researchers at the University of British Columbia (UBC).
Nouvelles du réseau
Le programme de bourses en technologie médicale, créé par Sunnybrook à Toronto, lance un deuxième programme avec le Centre d’innovation en santé de la Nouvelle-Écosse
Medventions, établie par Sunnybrook à Toronto, lance un deuxième programme avec le Nova Scotia Health Innovation Hub
Le Radialis PET Imager : l’écosystème d’innovation en santé de Thunder Bay nourrit une technologie de soins de santé de pointe
Lorsque vous pensez aux villes abritant et construisant des technologies médicales transformationnelles (medtech), votre première hypothèse n’est probablement pas « la ville au cœur géant ». Nichée à l’angle nord-ouest du lac Supérieur, Thunder Bay, en Ontario, abrite l’une des entreprises de technologie médicale les plus prometteuses du Canada, spécialisée dans la fabrication de dispositifs médicaux par tomographie par émission de positons, Radialis.
INOVAIT announces third round of funding for artificial intelligence and image-guided therapy projects
June 21, 2023 | Toronto, ON – INOVAIT, the pan-Canadian network for image-guided therapy (IGT) hosted by Sunnybrook...
Le programme Medventions de Sunnybrook s’étend au Canada atlantique en collaboration avec le Centre d’innovation en santé de la Nouvelle-Écosse
June 19 2023 | Today, Sunnybrook Research Institute (SRI) and INOVAIT are proud to announce the expansion of...
Série de conférences sur la TGI
Regulating AI in Image-Guided Therapy
Suivre INOVAIT sur les médias sociaux